Skip to main content
. 2021 May 5;12(3):779–795. doi: 10.1002/jcsm.12710

Figure 4.

Figure 4

DCSD attenuated cachexia symptoms of C26 tumour‐bearing mice. C26 tumour‐bearing mice were administrated DCSD (20 mg/kg) by intraperitoneal injection every day for 16 days, and healthy BALB/c mice and C26 model group mice received equal volume solvent. Body weight, food intake, body temperature, and tumour volume were recorded every day. (A) Body weight of mice. (B) Tumour‐free body weight of mice. (C) Accumulative food intake of mice. (D) Daily food intake of mice. (E) Body temperature of mice. (F) Tumour volume of mice. (G) Photo and weight of the isolated tumour tissues. Values are expressed as mean ± SEM (n = 8). *vs. health group mice; #vs. C26 model group mice. One‐way ANOVA test was performed followed by Bonferroni's post hoc test. ***P < 0.001, ##P < 0.01.